Bob Creeden, Managing Director of the Seed Fund and New Ventures for the UVA Licensing and Venture Group, will lead a discussion of the funding landscape for the commercialization of science.
David Touve, Senior Director, Ventures, Batten Institute for Entrepreneurship & Innovation
:: FOR FURTHER BACKGROUND ::
Kennedy, J. (2012). The sources and uses of U.S. science funding. The New Atlantis, Summer 2012, pp. 3-22.
Boroush, M. (2016). U.S. R&D Increased by More Than$20 Billion in Both 2013 and 2014, withSimilar Increase Estimated for 2015. National Center for Science and Engineering Statistics, p. 1-9.
Zider, B. (1998). How venture capital works. Harvard business review, 76(6), 131-139.